Tetracycline and trimethoprim/sulfamethoxazole at clinical laboratory: Can they help to characterize Staphylococcus aureus carrying different SCCmec types?
Rev. Soc. Bras. Med. Trop
; 46(1): 100-102, Jan.-Feb. 2013. tab
Article
em En
| LILACS
| ID: lil-666803
Biblioteca responsável:
BR1.1
ABSTRACT
INTRODUCTION:
Methicillin-resistant Staphylococcus aureus (MRSA) can be difficult to detect at the clinical practice.METHODS:
We analyzed 140 MRSA isolates from inpatients to correlate the antimicrobial susceptibility with the SCCmec types.RESULTS:
Type III (n = 63) isolates were more resistant to ciprofloxacin, clindamycin, cloramphenicol, erythromycin, gentamicin, and rifampin than type IV (n = 65) ones (p < 0.05). Moreover, type IV isolates were susceptible to tetracycline (100%) and trimethoprim/sulfamethoxazole (98%), while type III isolates presented resistance to them.CONCLUSIONS:
In regions where these SCCmec types are prevalent, the detection of specific resistant phenotypes could help to predict them, mainly when there are no technical conditions to SCCmec typing.Palavras-chave
Buscar no Google
Índice:
LILACS
Assunto principal:
Tetraciclina
/
Combinação Trimetoprima e Sulfametoxazol
/
Farmacorresistência Bacteriana Múltipla
/
Staphylococcus aureus Resistente à Meticilina
/
Antibacterianos
Limite:
Humans
Idioma:
En
Revista:
Rev. Soc. Bras. Med. Trop
Assunto da revista:
MEDICINA TROPICAL
Ano de publicação:
2013
Tipo de documento:
Article